• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 甲基化在肿瘤免疫中的作用及其临床意义。

Roles of RNA Methylation on Tumor Immunity and Clinical Implications.

机构信息

Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.

出版信息

Front Immunol. 2021 Mar 10;12:641507. doi: 10.3389/fimmu.2021.641507. eCollection 2021.

DOI:10.3389/fimmu.2021.641507
PMID:33777035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987906/
Abstract

RNA methylation is a kind of RNA modification that exists widely in eukaryotes and prokaryotes. RNA methylation occurs not only in mRNA but also in ncRNA. According to the different sites of methylation, RNA methylation includes mA, mC, mG, and 2-O-methylation modifications. Modifications affect the splicing, nucleation, stability and immunogenicity of RNA. RNA methylation is involved in many physiological and pathological processes. In the immune system, especially for tumor immunity, RNA methylation affects the maturation and response function of immune cells. Through the influence of RNA immunogenicity and innate immune components, modifications regulate the innate immunity of the body. Some recent studies verified that RNA methylation can regulate tumor immunity, which also provides a new idea for the future of treating immunological diseases and tumor immunotherapy.

摘要

RNA 甲基化是一种广泛存在于真核生物和原核生物中的 RNA 修饰。RNA 甲基化不仅发生在 mRNA 中,也发生在 ncRNA 中。根据甲基化的不同位点,RNA 甲基化包括 mA、mC、mG 和 2'-O-甲基化修饰。修饰影响 RNA 的剪接、起始、稳定性和免疫原性。RNA 甲基化参与许多生理和病理过程。在免疫系统中,特别是对于肿瘤免疫,RNA 甲基化影响免疫细胞的成熟和反应功能。通过影响 RNA 的免疫原性和先天免疫成分,修饰调节机体的先天免疫。一些最近的研究证实 RNA 甲基化可以调节肿瘤免疫,这也为未来治疗免疫性疾病和肿瘤免疫治疗提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/cf7a6e144bf8/fimmu-12-641507-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/548434b8cec5/fimmu-12-641507-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/e2932fe9ac07/fimmu-12-641507-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/cf7a6e144bf8/fimmu-12-641507-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/548434b8cec5/fimmu-12-641507-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/e2932fe9ac07/fimmu-12-641507-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e745/7987906/cf7a6e144bf8/fimmu-12-641507-g0003.jpg

相似文献

1
Roles of RNA Methylation on Tumor Immunity and Clinical Implications.RNA 甲基化在肿瘤免疫中的作用及其临床意义。
Front Immunol. 2021 Mar 10;12:641507. doi: 10.3389/fimmu.2021.641507. eCollection 2021.
2
A Review in Research Progress Concerning m6A Methylation and Immunoregulation.m6A 甲基化与免疫调控相关研究进展述评
Front Immunol. 2019 Apr 26;10:922. doi: 10.3389/fimmu.2019.00922. eCollection 2019.
3
The YTH domain-containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets.YTH 结构域蛋白家族:免疫调节和肿瘤免疫治疗靶点的新兴参与者。
Clin Transl Med. 2024 Aug;14(8):e1784. doi: 10.1002/ctm2.1784.
4
N-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target.N6-甲基腺苷在癌症免疫治疗中的作用:一个被低估的治疗靶点。
Front Immunol. 2021 Aug 30;12:697026. doi: 10.3389/fimmu.2021.697026. eCollection 2021.
5
Exosomes and tumor-mediated immune suppression.外泌体与肿瘤介导的免疫抑制。
J Clin Invest. 2016 Apr 1;126(4):1216-23. doi: 10.1172/JCI81136. Epub 2016 Feb 29.
6
N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.信使核糖核酸中的N6-甲基腺苷修饰:机制、功能及其对健康与疾病的影响
FEBS J. 2016 May;283(9):1607-30. doi: 10.1111/febs.13614. Epub 2015 Dec 31.
7
A fly view on the roles and mechanisms of the mA mRNA modification and its players.mA 信使 RNA 修饰及其相关分子的作用和机制的概述
RNA Biol. 2017 Sep 2;14(9):1232-1240. doi: 10.1080/15476286.2017.1307484. Epub 2017 Mar 29.
8
The interplay between m6A RNA methylation and noncoding RNA in cancer.m6A RNA 甲基化与癌症中非编码 RNA 的相互作用。
J Hematol Oncol. 2019 Nov 22;12(1):121. doi: 10.1186/s13045-019-0805-7.
9
Methylation modifications in eukaryotic messenger RNA.真核信使 RNA 的甲基化修饰。
J Genet Genomics. 2014 Jan 20;41(1):21-33. doi: 10.1016/j.jgg.2013.10.002. Epub 2013 Nov 9.
10
Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.表观转录组学:HIV 转基因大鼠海马中 N6-甲基腺苷 RNA 甲基化与通路失调的相关性。
PLoS One. 2019 Jan 17;14(1):e0203566. doi: 10.1371/journal.pone.0203566. eCollection 2019.

引用本文的文献

1
Comprehensive Analysis of Differentially Expressed Profiles of mRNA 5-Methylcytosine Modification in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病中mRNA 5-甲基胞嘧啶修饰差异表达谱的综合分析
Curr Issues Mol Biol. 2025 Apr 26;47(5):305. doi: 10.3390/cimb47050305.
2
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
3
Integrative Role of RNA N7-methylguanosine in epilepsy: Regulation of neuronal oxidative phosphorylation, programmed death and immune microenvironment.

本文引用的文献

1
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.N6-甲基腺苷甲基转移酶分析揭示METTL14和ZC3H13为乳腺癌中的肿瘤抑制基因。
Front Oncol. 2020 Dec 9;10:578963. doi: 10.3389/fonc.2020.578963. eCollection 2020.
2
The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma.m6A阅读蛋白YTHDC2是一种潜在的生物标志物,与头颈部鳞状细胞癌中的免疫浸润相关。
PeerJ. 2020 Nov 26;8:e10385. doi: 10.7717/peerj.10385. eCollection 2020.
3
RNA methylations in human cancers.
RNA N7-甲基鸟苷在癫痫中的整合作用:对神经元氧化磷酸化、程序性死亡和免疫微环境的调节
PLoS One. 2025 Jul 14;20(7):e0327256. doi: 10.1371/journal.pone.0327256. eCollection 2025.
4
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
5
N6-Methyladenosine Modification of the Three Components "Writers", "Erasers", and "Readers" in Relation to Osteogenesis.与成骨相关的“书写者”“擦除者”和“阅读者”三种组分的N6-甲基腺苷修饰
Int J Mol Sci. 2025 Jun 12;26(12):5620. doi: 10.3390/ijms26125620.
6
Role of m5C methylation in digestive system tumors (Review).m5C甲基化在消化系统肿瘤中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13507. Epub 2025 Apr 4.
7
The multifaceted role of m5C RNA methylation in digestive system tumorigenesis.m5C RNA甲基化在消化系统肿瘤发生中的多方面作用
Front Cell Dev Biol. 2025 Mar 6;13:1533148. doi: 10.3389/fcell.2025.1533148. eCollection 2025.
8
Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma.肺鳞状细胞癌中M7G免疫相关基因的预后分析与鉴定
Front Immunol. 2025 Mar 3;16:1515838. doi: 10.3389/fimmu.2025.1515838. eCollection 2025.
9
Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma.m7G甲基化相关基因预后特征与免疫治疗的综合分析以及LARP1作为头颈部鳞状细胞癌关键癌基因的鉴定
Front Immunol. 2025 Feb 13;16:1520070. doi: 10.3389/fimmu.2025.1520070. eCollection 2025.
10
Detection, molecular function and mechanisms of m5C in cancer.癌症中m5C的检测、分子功能及机制
Clin Transl Med. 2025 Mar;15(3):e70239. doi: 10.1002/ctm2.70239.
人类癌症中的 RNA 甲基化。
Semin Cancer Biol. 2021 Oct;75:97-115. doi: 10.1016/j.semcancer.2020.11.007. Epub 2020 Nov 18.
4
M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.M6A 调控基因在胰腺导管腺癌的预后、进展和免疫微环境中发挥重要作用。
Cancer Invest. 2021 Jan;39(1):39-54. doi: 10.1080/07357907.2020.1834576. Epub 2020 Nov 12.
5
-methyladenosine (mA) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules.-甲基腺苷(mA)RNA甲基化特征作为胃腺癌预后的预测指标及其与免疫检查点分子的关联
J Int Med Res. 2020 Sep;48(9):300060520951405. doi: 10.1177/0300060520951405.
6
m A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.m6A 甲基转移酶 METTL3/14 调控抗 PD-1 治疗的免疫应答。
EMBO J. 2020 Oct 15;39(20):e104514. doi: 10.15252/embj.2020104514. Epub 2020 Sep 23.
7
RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.RNA N6-甲基腺嘌呤去甲基酶 FTO 调控结肠癌细胞中 PD-L1 的表达。
Biochem Biophys Res Commun. 2020 Sep 10;530(1):235-239. doi: 10.1016/j.bbrc.2020.06.153. Epub 2020 Aug 4.
8
Expression pattern of mA regulators is significantly correlated with malignancy and antitumor immune response of breast cancer.mA 调节剂的表达模式与乳腺癌的恶性程度和抗肿瘤免疫反应显著相关。
Cancer Gene Ther. 2021 Apr;28(3-4):188-196. doi: 10.1038/s41417-020-00208-1. Epub 2020 Aug 6.
9
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.ALKBH5 通过调节肿瘤微环境中的乳酸和抑制性免疫细胞积累来调控抗 PD-1 治疗反应。
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20159-20170. doi: 10.1073/pnas.1918986117. Epub 2020 Aug 3.
10
IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6A modification of circ_0029589 in patients with acute coronary syndrome.IFN 调节因子-1 通过调节急性冠状动脉综合征患者 circ_0029589 的 m6A 修饰诱导巨噬细胞焦亡。
Int Immunopharmacol. 2020 Sep;86:106800. doi: 10.1016/j.intimp.2020.106800. Epub 2020 Jul 13.